Lyka Labs Secures NCLT Merger Approval and Confirms FY26 Compliance

Lyka Labs Limited has received official approval from the National Company Law Tribunal (NCLT) for the merger of Lyka Exports Limited into Lyka Labs Limited. The NCLT's Ahmedabad Bench granted this approval on March 16, 2026, following procedures outlined in Sections 230-232 of the Companies Act, 2013.

Merger Finalized, Compliance Confirmed

The NCLT, Ahmedabad Bench, has now formally sanctioned the merger scheme between Lyka Exports Limited and Lyka Labs Limited. This corporate milestone, finalized on March 16, 2026, represents a key step in the company's restructuring.

In parallel, Lyka Labs Limited has submitted its Annual Secretarial Compliance Report covering the year ended March 31, 2026. Prepared by M/s. Kaushal Doshi & Associates, the report affirms the company's complete adherence to all relevant SEBI regulations and directives.

Strategic Consolidation and Investor Confidence

This NCLT approval enables Lyka Labs Limited to fully absorb Lyka Exports Limited. The integration is anticipated to create operational efficiencies and a more unified corporate framework, signaling strategic progress for shareholders.

The confirmation of robust regulatory compliance bolsters investor confidence by highlighting the company's commitment to strong governance and legal standards.

Merger Background

The merger with Lyka Exports Limited is part of Lyka Labs Limited's ongoing strategic restructuring. Clearing the NCLT approval signifies the final major regulatory step for this consolidation.

Lyka Labs has consistently maintained its focus on regulatory adherence, as demonstrated by its regular secretarial compliance reports.

Integration and Future Growth

Following the NCLT's go-ahead, the merger process will proceed, integrating Lyka Exports Limited into Lyka Labs Limited. This move is expected to improve overall operational performance and enhance the company's market standing.

The company's dedication to compliance ensures it operates within the required legal parameters, supporting a stable environment for future expansion.

Potential Integration Risks

While the merger has been approved, the success of operational integration and the realization of expected synergies are critical. Any hurdles or delays during this integration phase could present challenges.

Maintaining ongoing compliance with evolving SEBI regulations and corporate governance standards remains a key priority.

Industry Context

Consolidating through mergers and acquisitions is a common strategy within the industry, aimed at achieving economies of scale and strengthening market presence. Lyka Labs' action aligns with these typical industry practices.

For all entities listed on Indian stock exchanges, strict regulatory compliance is a fundamental requirement.

Key Dates

• Compliance Period: Year ended March 31, 2026
• Merger Approval Date: March 16, 2026

Next Steps for Investors

Investors will likely track the progress of post-merger integration and any subsequent operational updates or financial results stemming from the consolidation of Lyka Exports Limited into Lyka Labs Limited.